PYC Therapeutics Limited (PYCXF)

PYC Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 11, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	704	495	374	127	142	370
Market Cap Growth	127.93%	32.55%	193.38%	-10.61%	-61.46%	58.81%
Enterprise Value	597	464	358	117	113	329
Last Close Price	1.26	0.67	-	-	-	-
PS Ratio	45.74	32.15	25.38	12.10	12.89	160.37
PB Ratio	6.32	4.44	6.91	6.73	5.14	9.14
P/TBV Ratio	6.48	4.56	7.33	8.14	5.92	10.19
EV/Sales Ratio	35.67	30.12	24.29	11.10	10.26	142.63
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01
Net Debt / Equity Ratio	-0.89	-0.89	-0.81	-0.54	-0.70	-0.94
Net Debt / EBITDA Ratio	2.88	2.88	1.73	0.67	2.06	2.77
Net Debt / FCF Ratio	2.89	2.89	1.69	0.61	1.27	4.10
Asset Turnover	0.17	0.17	0.34	0.38	0.31	0.07
Quick Ratio	14.38	14.38	9.32	3.79	8.93	15.68
Current Ratio	14.41	14.41	9.40	3.79	8.95	15.71
Return on Equity (ROE)	-40.64%	-40.64%	-69.61%	-68.05%	-30.37%	-44.29%
Return on Assets (ROA)	-24.42%	-24.42%	-37.83%	-35.49%	-17.29%	-26.20%
Return on Capital Employed (ROCE)	-31.40%	-31.40%	-47.30%	-81.50%	-34.90%	-34.30%
Earnings Yield	-4.68%	-6.66%	-6.74%	-11.91%	-6.71%	-3.60%
FCF Yield	-4.89%	-6.96%	-6.95%	-13.02%	-10.72%	-2.51%
Buyback Yield / Dilution	-27.16%	-27.16%	-22.59%	-0.93%	-2.89%	-12.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.